172 related articles for article (PubMed ID: 37420006)
1. Activation of distinct inflammatory pathways in subgroups of LR-MDS.
Schneider M; Rolfs C; Trumpp M; Winter S; Fischer L; Richter M; Menger V; Nenoff K; Grieb N; Metzeler KH; Kubasch AS; Sockel K; Thiede C; Wu J; Woo J; Brüderle A; Hofbauer LC; Lützner J; Roth A; Cross M; Platzbecker U
Leukemia; 2023 Aug; 37(8):1709-1718. PubMed ID: 37420006
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDS.
Kornblau SM; Cohen AC; Soper D; Huang YW; Cesano A
Cytometry B Clin Cytom; 2014 Nov; 86(6):383-96. PubMed ID: 24106013
[TBL] [Abstract][Full Text] [Related]
3. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Verma A; Norbury CJ; Hellström-Lindberg E; Wainscoat JS; Boultwood J
Leukemia; 2010 Apr; 24(4):756-64. PubMed ID: 20220779
[TBL] [Abstract][Full Text] [Related]
4. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice.
Wei Y; Zheng H; Bao N; Jiang S; Bueso-Ramos CE; Khoury J; Class C; Lu Y; Lin K; Yang H; Ganan-Gomez I; Starczynowski DT; Do KA; Colla S; Garcia-Manero G
Blood Adv; 2018 Oct; 2(19):2491-2504. PubMed ID: 30275007
[TBL] [Abstract][Full Text] [Related]
5. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
6. What is the role of the microenvironment in MDS?
Calvi LM; Li AJ; Becker MW
Best Pract Res Clin Haematol; 2019 Dec; 32(4):101113. PubMed ID: 31779976
[TBL] [Abstract][Full Text] [Related]
7. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
Dolatshad H; Pellagatti A; Fernandez-Mercado M; Yip BH; Malcovati L; Attwood M; Przychodzen B; Sahgal N; Kanapin AA; Lockstone H; Scifo L; Vandenberghe P; Papaemmanuil E; Smith CW; Campbell PJ; Ogawa S; Maciejewski JP; Cazzola M; Savage KI; Boultwood J
Leukemia; 2015 May; 29(5):1092-103. PubMed ID: 25428262
[TBL] [Abstract][Full Text] [Related]
8. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
Dimitriou M; Woll PS; Mortera-Blanco T; Karimi M; Wedge DC; Doolittle H; Douagi I; Papaemmanuil E; Jacobsen SE; Hellström-Lindberg E
Oncotarget; 2016 Nov; 7(45):72685-72698. PubMed ID: 27683035
[TBL] [Abstract][Full Text] [Related]
9. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
Ainciburu M; Ezponda T; Berastegui N; Alfonso-Pierola A; Vilas-Zornoza A; San Martin-Uriz P; Alignani D; Lamo-Espinosa J; San-Julian M; Jiménez-Solas T; Lopez F; Muntion S; Sanchez-Guijo F; Molero A; Montoro J; Serrano G; Diaz-Mazkiaran A; Lasaga M; Gomez-Cabrero D; Diez-Campelo M; Valcarcel D; Hernaez M; Romero JP; Prosper F
Elife; 2023 Jan; 12():. PubMed ID: 36629404
[TBL] [Abstract][Full Text] [Related]
10. Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.
Ward GA; Dalton RP; Meyer BS; McLemore AF; Aldrich AL; Lam NB; Onimus AH; Vincelette ND; Trinh TL; Chen X; Calescibetta AR; Christiansen SM; Hou HA; Johnson JO; Wright KL; Padron E; Eksioglu EA; List AF
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835307
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic
Osswald L; Hamarsheh S; Uhl FM; Andrieux G; Klein C; Dierks C; Duquesne S; Braun LM; Schmitt-Graeff A; Duyster J; Boerries M; Brummer T; Zeiser R
Mol Cancer Res; 2021 Sep; 19(9):1596-1608. PubMed ID: 34088868
[TBL] [Abstract][Full Text] [Related]
12. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients.
Langemeijer SM; Mariani N; Knops R; Gilissen C; Woestenenk R; de Witte T; Huls G; van der Reijden BA; Jansen JH
PLoS One; 2016; 11(11):e0165582. PubMed ID: 27902785
[TBL] [Abstract][Full Text] [Related]
14. Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.
Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V
Clin Cancer Res; 2012 Jun; 18(11):3079-89. PubMed ID: 22496271
[TBL] [Abstract][Full Text] [Related]
15. A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes.
Peng H; Wen J; Zhang L; Li H; Chang CC; Zu Y; Zhou X
Mol Biosyst; 2012 Apr; 8(4):1366-74. PubMed ID: 22327869
[TBL] [Abstract][Full Text] [Related]
16. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.
Schinke C; Giricz O; Li W; Shastri A; Gordon S; Barreyro L; Bhagat T; Bhattacharyya S; Ramachandra N; Bartenstein M; Pellagatti A; Boultwood J; Wickrema A; Yu Y; Will B; Wei S; Steidl U; Verma A
Blood; 2015 May; 125(20):3144-52. PubMed ID: 25810490
[TBL] [Abstract][Full Text] [Related]
17. Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis.
McGraw KL; Cheng CH; Chen YA; Hou HA; Nilsson B; Genovese G; Cluzeau T; Pellagatti A; Przychodzen BP; Mallo M; Arenillas L; Mohamedali A; Adès L; Sallman DA; Padron E; Sokol L; Moreilhon C; Raynaud S; Tien HF; Boultwood J; Ebert BL; Sole F; Fenaux P; Mufti GJ; Maciejewski JP; Kanetsky PA; List AF
Blood Adv; 2019 Nov; 3(22):3579-3589. PubMed ID: 31738830
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.
Gañán-Gómez I; Wei Y; Yang H; Pierce S; Bueso-Ramos C; Calin G; Boyano-Adánez Mdel C; García-Manero G
PLoS One; 2014; 9(4):e93404. PubMed ID: 24690917
[TBL] [Abstract][Full Text] [Related]
19. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
[TBL] [Abstract][Full Text] [Related]
20. SWI/SNF subunit expression heterogeneity in human aplastic anemia stem/progenitors.
Sinha S; Chatterjee SS; Biswas M; Nag A; Banerjee D; De R; Sengupta A
Exp Hematol; 2018 Jun; 62():39-44.e2. PubMed ID: 29596882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]